白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%

中金财经

Dec 15, 2025

　　h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年12月15日收盘，白云山(600332)报收于25.69元，较前一交易日下跌1.31%，最新总市值为417.67亿元。该股当日开盘25.79元，最高25.79元，最低25.46元，成交额达5.86亿元，换手率为1.63%。近日，广东省药品监督管理局发布通告，广州白云山医药集团股份有限公司子公司广州白云山星珠药业有限公司的《药品生产许可证》已注销。本次注销原因为星珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。该证有效期至2025年9月9日，生产范围为中药饮片(净制、切制、炒制、蒸制、炙制)。星珠药业2024年中药饮片业务未产生营业收入，本次注销对其生产经营无影响，对公司当期业绩无重大影响。最新公告列表《广州白云山医药集团股份有限公司关于子公司《药品生产许可证》注销的公告》为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2591610368"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2591610368\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2591610368?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-12-15 18:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2591610368","market":"fut","top_or_hot":-1,"title":"白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%","media":"中金财经","content":"<html><body><p>　　h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年12月15日收盘，<a href=\"https://laohu8.com/S/600332\">白云山</a>(600332)报收于25.69元，较前一交易日下跌1.31%，最新总市值为417.67亿元。该股当日开盘25.79元，最高25.79元，最低25.46元，成交额达5.86亿元，换手率为1.63%。近日，广东省药品监督管理局发布通告，广州<a href=\"https://laohu8.com/S/00874\">白云山</a>医药集团股份有限公司子公司广州白云山星珠药业有限公司的《药品生产许可证》已注销。本次注销原因为星珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。该证有效期至2025年9月9日，生产范围为中药饮片(净制、切制、炒制、蒸制、炙制)。星珠药业2024年中药饮片业务未产生营业收入，本次注销对其生产经营无影响，对公司当期业绩无重大影响。最新公告列表《广州白云山医药集团股份有限公司关于子公司《药品生产许可证》注销的公告》为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。 </p></body></html>","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n白云山（600332）披露子公司《药品生产许可证》注销公告，12月15日股价下跌1.31%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-15 18:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushiyaowen/20251215/31866395.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年12月...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushiyaowen/20251215/31866395.shtml\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251215/31866395.shtml","article_id":"2591610368","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2591610368","pubTimestamp":1765793980,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"近日，广东省药品监督管理局发布通告，广州白云山医药集团股份有限公司子公司广州白云山星珠药业有限公司的《药品生产许可证》已注销。本次注销原因为星珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。星珠药业2024年中药饮片业务未产生营业收入，本次注销对其生产经营无影响，对公司当期业绩无重大影响。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600332":"白云山","BK0183":"MSCI概念","BK1191":"制药","BK0188":"融资融券","BK0070":"员工持股","BK0097":"医药电商","00874":"白云山","BK1606":"中医药概念","BK0012":"证金概念","BK1521":"挪威政府全球养老基金持仓","BK0175":"白马股","BK0096":"民营医院","BK1515":"抗疫概念","BK0028":"国家队","BK0196":"行业龙头","BK0239":"医药制造","BK1197":"保健护理产品经销商"},"translate_title":"Baiyunshan (600332) disclosed the cancellation announcement of its subsidiary's \"Drug Production License\", and its stock price fell 1.31% on December 15","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1.5,"00874":1.5},"content_text":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年12月15日收盘，白云山(600332)报收于25.69元，较前一交易日下跌1.31%，最新总市值为417.67亿元。该股当日开盘25.79元，最高25.79元，最低25.46元，成交额达5.86亿元，换手率为1.63%。近日，广东省药品监督管理局发布通告，广州白云山医药集团股份有限公司子公司广州白云山星珠药业有限公司的《药品生产许可证》已注销。本次注销原因为星珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。该证有效期至2025年9月9日，生产范围为中药饮片(净制、切制、炒制、蒸制、炙制)。星珠药业2024年中药饮片业务未产生营业收入，本次注销对其生产经营无影响，对公司当期业绩无重大影响。最新公告列表《广州白云山医药集团股份有限公司关于子公司《药品生产许可证》注销的公告》为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}